Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: terrible terrible muscle pains that lasted for two weeks; felt sick; skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm; skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm; skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm; skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (terrible terrible muscle pains that lasted for two weeks), MALAISE (felt sick), VACCINATION SITE ERYTHEMA (skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm), VACCINATION SITE RASH (skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm) and VACCINATION SITE WARMTH (skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032L20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA) for Asthma, CALCIUM FOLINATE (FOLINATE) and FAMOTIDINE (PEPCID AC) for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced MALAISE (felt sick), VACCINATION SITE ERYTHEMA (skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm), VACCINATION SITE RASH (skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm), VACCINATION SITE WARMTH (skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm) and VACCINATION SITE PRURITUS (skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm). On an unknown date, the patient experienced MYALGIA (terrible terrible muscle pains that lasted for two weeks). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and HYDROCORTISONE (CORTISONE [HYDROCORTISONE]) (topical) at an unspecified dose and frequency. At the time of the report, MYALGIA (terrible terrible muscle pains that lasted for two weeks), MALAISE (felt sick), VACCINATION SITE ERYTHEMA (skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm), VACCINATION SITE RASH (skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm), VACCINATION SITE WARMTH (skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm) and VACCINATION SITE PRURITUS (skin rash, that was inflamed, red, itchy and hot near the injection site, sometimes referred as covid arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient treatment included  icing, antibiotic ointment for the rash and cortisone cream for the itching.